Stimwave Technologies News Today

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Laura Tyler Perryman, co-founder and former…

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

The U.S. Securities and Exchange Commission on Tuesday accused the former CEO of bankrupt medical device maker Stimwave Technologies of defrauding investors out of roughly $41 million, filing a civil suit against the embattled executive the same day federal prosecutors lodged a superseding indictment in her criminal case.

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

The buyer of Stimwave Technologies can force the medical device company's former CEO and her family to relinquish control of a domain name used to direct patients to information about faulty implants, a Delaware bankruptcy judge said Wednesday, calling the family's alleged efforts to redirect web traffic "immoral."

A Delaware bankruptcy court judge approved $12 million in interim financing for medical device company Stimwave Technologies at a first-day hearing Thursday, overruling objections from equity holders that the company was shutting them out.